Clayton Russell - Insider Non-Derivative Transactions at Larimar Therapeutics, Inc. (LRMR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 17, 2024, Clayton Russell's relationship to Larimar Therapeutics, Inc. (LRMR) is Officer (Chief Medical Officer), and currently has 22,500 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LRMR insiders.

Data Source: SEC.
Clayton Russell - Insider Non-Derivative Transactions of LRMR Common Stock
Clayton Russell - Insider Non-Derivative Transactions at LRMR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 18, 2024 Acquisition -- (Common Stock) 22500 0 22500